Jazz Pharmaceuticals
In Howard Marks's portfolio · Oaktree Capital Management
Ticker JAZZ.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2020 | Add 363% | 19,038,000 | 0.5% |
| Q2 2017 | Reduce 6% | 34,343,000 | 0.6% |
| Q1 2017 | Buy | 36,497,000 | 0.6% |
| Q3 2016 | Sell | 0 | |
| Q2 2016 | Reduce 16% | 68,407,000 | 1.3% |
| Q1 2016 | Reduce 15% | 81,496,000 | 1.5% |
| Q4 2015 | Reduce 10% | 96,080,000 | 1.3% |
| Q3 2015 | Buy | 106,480,000 | 1.4% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.